Greenlight Capital - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
Greenlight Capital ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,929,985
-21.2%
588,410
+7.7%
0.11%
-4.3%
Q2 2023$2,448,589
-7.1%
546,5600.0%0.12%
-19.6%
Q1 2023$2,634,419
+54.0%
546,5600.0%0.14%
+21.2%
Q4 2022$1,710,732
-3.9%
546,5600.0%0.12%
-6.3%
Q3 2022$1,781,000
-9.5%
546,5600.0%0.13%
-17.6%
Q2 2022$1,967,000
-12.0%
546,5600.0%0.15%
+7.7%
Q1 2022$2,236,000
-24.7%
546,5600.0%0.14%
-16.5%
Q4 2021$2,968,000
-27.1%
546,5600.0%0.17%
-37.7%
Q3 2021$4,069,000
-25.6%
546,5600.0%0.27%
-20.4%
Q2 2021$5,466,000
-33.0%
546,5600.0%0.34%
-39.6%
Q1 2021$8,155,000546,5600.57%
Other shareholders

There were no reported owners of GAIN THERAPEUTICS INC in Q2 2023.

NameSharesValueWeighting ↓
View complete list of GAIN THERAPEUTICS INC shareholders